Caries Risk in Children Treated Under General Anesthesia for Early Childhood Caries

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-16
SponsorAydin Adnan Menderes University

About this trial

This observational, cross-sectional study aims to evaluate the current caries risk profiles of children who underwent dental treatment under general anesthesia (GA) for early childhood caries (ECC) between 2015 and 2020 at Aydın Adnan Menderes University, Faculty of Dentistry. A minimum of 44 systemically healthy children will be included.

Caries risk will be assessed using the Cariogram model, incorporating clinical parameters (DMFT/dmft, Plaque Index, Gingival Index, probing depth), salivary factors (stimulated flow rate, buffer capacity), and standardized questionnaires covering diet, fluoride exposure, socioeconomic status, and dental visit history. Data will be collected in a single visit, analyzed using SPSS.

The study aims to provide scientific evidence for long-term preventive strategies and oral health policies targeting high-risk pediatric populations treated under GA for ECC.

Eligibility criteria

Qualifiers

Pediatric patients who underwent dental treatment under general anesthesia for early childhood caries (ECC) at the Department of Pediatric Dentistry, Faculty of Dentistry, Aydın Adnan Menderes University between 2015-2020

Patients whose follow-up information (e.g., discharge summary, treatment plan) is accessible through clinical records

Individuals who provide written informed consent signed by their parents/legal guardians and assent from the child to participate in the study

Disqualifiers

Individuals with medical conditions that may affect oral health, such as systemic diseases, immunodeficiencies, or chronic illnesses

Children with special healthcare needs or mental/physical disabilities

Patients who do not cooperate during the examination or do not allow the completion of the oral examination

Trial design

Treatments tested in this trial

  • Caries Risk Assesment

Treatment groups

44 Participants
are divided into 1 treatment group